Profile of plecanatide in the treatment of chronic idiopathic constipation: design, development, and place in therapy

References

• HigginsPDJohansonJFEpidemiology of constipation in North America: a systematic reviewAm J Gastroenterol200499475075915089911
   PubMed Web of Science ®Google Scholar
• SonnenbergAKochTRPhysician visits in the United States for constipation: 1958 to 1986Dig Dis Sci19893446066112784759
   PubMed Web of Science ®Google Scholar
• RaoSSConstipation: evaluation and treatment of colonic and anorectal motility disordersGastroenterol Clin North Am200736368771117950444
   PubMed Web of Science ®Google Scholar
• RaoSSSeatonKMillerMJPsychological profiles and quality of life differ between patients with dyssynergia and those with slow transit constipationJ Psychosom Res200763444144917905054
   PubMed Web of Science ®Google Scholar
• SuaresNCFordACSystematic review: the effects of fibre in the management of chronic idiopathic constipationAliment Pharmacol Ther201133889590121332763
   PubMed Web of Science ®Google Scholar
• BharuchaAEDornSDLemboAPressmanAAmerican Gastroenterological Association medical position statement on constipationGastroenterology2013144121121723261064
   PubMed Web of Science ®Google Scholar
• HarrisLAHornJKissous-HuntMMagnusLQuigleyEMMThe better understanding and recognition of the disconnects, experiences, and needs of patients with chronic idiopathic constipation (BURDEN-CIC) study: results of an online questionnaireAdv Ther201734122661267329110286
   PubMed Web of Science ®Google Scholar
• CastroJHarringtonAMHughesPALinaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3′,5′-monophosphateGastroenterology2013145613341346.e1–1123958540
   PubMed Web of Science ®Google Scholar
• Silos-SantiagoIHannigGEutameneHGastrointestinal pain: unraveling a novel endogenous pathway through uroguanylin/guanylate cyclase-C/cGMP activationPain201315491820183023748116
   PubMed Web of Science ®Google Scholar
• WaldmanSACamilleriMGuanylate cyclase-C as a therapeutic target in gastrointestinal disordersGut20186781543155229563144
   PubMed Web of Science ®Google Scholar
• SteinbrecherKAHarmel-LawsEGarin-LaflamMPMurine gua-nylate cyclase C regulates colonic injury and inflammationJ Immunol2011186127205721421555532
   PubMed Web of Science ®Google Scholar
• HanXMannEGilbertSLoss of guanylyl cyclase C (GCC) signaling leads to dysfunctional intestinal barrierPLoS One201161e1613921305056
   PubMed Web of Science ®Google Scholar
• ShailubhaiKYuHHKarunanandaaKUroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMPCancer Res200060185151515711016642
   PubMed Web of Science ®Google Scholar
• QianXPrabhakarSNandiAVisweswariahSSGoyMFExpression of GC-C, a receptor-guanylate cyclase, and its endogenous ligands uroguanylin and guanylin along the rostrocaudal axis of the intestineEndocrinology200014193210322410965892
   PubMed Web of Science ®Google Scholar
• HamraFKEberSLChinDTCurrieMGForteLRRegulation of intestinal uroguanylin/guanylin receptor-mediated responses by mucosal acidityProc Natl Acad Sci U S A1997946270527109122260
   PubMed Web of Science ®Google Scholar
• ShailubhaiKPalejwalaVArjunanKPPlecanatide and dolcanatide, novel guanylate cyclase-C agonists, ameliorate gastrointestinal inflammation in experimental models of murine colitisWorld J Gastrointest Pharmacol Ther20156421322226558155
   PubMedGoogle Scholar
• ShailubhaiKComiskeySFossJAPlecanatide, an oral guanylate cyclase C agonist acting locally in the gastrointestinal tract, is safe and well-tolerated in single dosesDig Dis Sci20135892580258623625291
   PubMed Web of Science ®Google Scholar
• ShailubhaiKTallutoCComiskeySA phase IIa randomized, double blind, placebo-controlled, 14-day repeat, oral, range-finding study to assess the safety, pharmacokinetic and pharmacodynamic effects of plecanatide (SP-304) in patients with chronic idiopathic constipation (Protocol No. SP-SP304201-09)Poster presented at: Digestive Disease Week (DDW)2010New Orleans, LA
   Google Scholar
• MinerPBSurowitzRFogelR925g Plecanatide, a novel guanylate cyclase-C (GC-C) receptor agonist, is efficacious and safe in patients with chronic idiopathic constipation (CIC): results from a 951 patient, 12 week, multi-center trialGastroenterology20131445S163
   Web of Science ®Google Scholar
• MitsuhashiSBallouSJiangZGCharacterizing normal bowel frequency and consistency in a representative sample of adults in the United States (NHANES)Am J Gastroenterol2018113111512328762379
   PubMed Web of Science ®Google Scholar
• DemiccoMBarrowLHickeyBShailubhaiKGriffinPRandomized clinical trial: efficacy and safety of plecanatide in the treatment of chronic idiopathic constipationTherap Adv Gastroenterol20171011837851
   PubMed Web of Science ®Google Scholar
• MinerPBKoltunWDWienerGJA randomized phase III clinical trial of plecanatide, a uroguanylin analog, in patients with chronic idiopathic constipationAm J Gastroenterol2017112461362128169285
   PubMed Web of Science ®Google Scholar
• BarishCFGriffinPSafety and tolerability of plecanatide in patients with chronic idiopathic constipation: long-term evidence from an open-label studyCurr Med Res Opin201834475175529343131
   PubMed Web of Science ®Google Scholar
• RaoSSYuSFedewaASystematic review: dietary fibre and FOD-MAP-restricted diet in the management of constipation and irritable bowel syndromeAliment Pharmacol Ther201541121256127025903636
   PubMed Web of Science ®Google Scholar
• AshrafWParkFLofJQuigleyEMEffects of psyllium therapy on stool characteristics, colon transit and anorectal function in chronic idiopathic constipationAliment Pharmacol Ther1995966396478824651
   PubMed Web of Science ®Google Scholar
• CheskinLJKamalNCr4wellMDSchusterMMWhiteheadWEMechanisms of constipation in older persons and effects of fiber compared with placeboJ Am Geriatr Soc19954366666697775727
   PubMed Web of Science ®Google Scholar
• AttaluriADonahoeRValestinJBrownKRaoSSRandomised clinical trial: dried plums (prunes) vs. psyllium for constipationAliment Pharmacol Ther201133782282821323688
   PubMed Web of Science ®Google Scholar
• ErdoganARaoSSThiruvaiyaruDRandomised clinical trial: mixed soluble/insoluble fibre vs. psyllium for chronic constipationAliment Pharmacol Ther2016441354427125883
   PubMed Web of Science ®Google Scholar
• JooJSEhrenpreisEDGonzalezLAlterations in colonic anatomy induced by chronic stimulant laxatives: the cathartic colon revisitedJ Clin Gastroenterol19982642832869649012
   PubMed Web of Science ®Google Scholar
• ShahEDKimHMSchoenfeldPEfficacy and tolerability of guanylate cyclase-C agonists for irritable bowel syndrome with constipation and chronic idiopathic constipation: a systematic review and meta-analysisAm J Gastroenterol2018113332933829380823
   PubMed Web of Science ®Google Scholar
• JohansonJFMortonDGeenenJUenoRMulticenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipationAm J Gastroenterol2008103117017717916109
   PubMed Web of Science ®Google Scholar
• FordACMoayyediPLacyBETask Force on the Management of Functional Bowel Disorders. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipationAm J Gastroenterol2014109Suppl 1S2S2625091148
   PubMed Web of Science ®Google Scholar
• LemboAJJohansonJFParkmanHPRaoSSMinerPBUenoRLong-term safety and effectiveness of lubiprostone, a chloride channel (ClC-2) activator, in patients with chronic idiopathic constipationDig Dis Sci20115692639264521769655
   PubMed Web of Science ®Google Scholar